About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6573 record(s)
Req # A-2023-001176
Information and documents submitted by Exegi Pharma, Limited Liability Company (LLC) to Health Canada in 2014 and 2015 seeking a Natural Health Product Licence for the Visbiome product which issued as Natural Product Number (NPN) 80061901.Organization: Health Canada
January 2025
Req # A-2023-001193
All documents prepared within Health Canada mentioning Melissa Lantsman. Topics include but are not limited to border closures, vaccination mandates, travel restrictions and COVID-19. September. 20, 2021 to December 18, 2023.Organization: Health Canada
January 2025
Req # A-2023-001402
The dates the GlobalCure SC6 laser, manufactured by Advanced Technology Laser Co. Ltd (China) and sold by Silhouet-Tone (Quebec, Canada) was legally allowed to be sold in Canada. Information regarding whether Silhouet-Tone is or was allowed to sell…Organization: Health Canada
January 2025
Req # A-2023-001528
The complaint documents associated with the 24 warning letters and records documenting the 1 administrative monetary penalty for drift complaints between 2020 and 2023.Organization: Health Canada
January 2025
Req # A-2023-001544
Health Risk Assessment (HRA) reports and related summaries for the following devices Q-NCOV-01G, 09COV37H, 99COV130J-ML04, 09COV120J, 09COV120H, sold by La Roche, Switch Health and CanAMScientific.Organization: Health Canada
January 2025
Req # A-2024-000013
Daily Essential Nutrients is actively marketed to Canadians on American websites. Any documents showing that a submission was made to Health Canada and if so whether it was found to have concerning nutrient dosing and therefore refused a Natural…Organization: Health Canada
January 2025
Req # A-2024-000014
The initial cover letter and any other document indicating the brand name of the reference drug product and the dosage form of the generic drug for the medicinal ingredient Ciclesonide. The Screening Acceptance Letter from Health Canada to the…Organization: Health Canada
January 2025
Req # A-2024-000161
All documents pertaining to Meril medical devices used as part of the Special Access Program.Organization: Health Canada
January 2025
Req # A-2024-000206
All documents submitted to Health Canada relating to the supplemental new drug submission underlying the Notice of Compliance (NOC) that issued on March 27, 2024 in respect of the product TRELSTAR and all related correspondence between the sponsor…Organization: Health Canada
January 2025
Req # A-2024-000300
For November 6, 2019, all meeting notes, briefing notes and memoranda sent or received by the Deputy Minister regarding the Hazardous Products Act, including its true copy of a label requirement.Organization: Health Canada
January 2025